417 related articles for article (PubMed ID: 19398334)
1. Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads.
Singh P; Kaur M; Verma P
Bioorg Med Chem Lett; 2009 Jun; 19(11):3054-8. PubMed ID: 19398334
[TBL] [Abstract][Full Text] [Related]
2. 1-Toluene-sulfonyl-3-[(3'-hydroxy-5'-substituted)-gamma-butyrolactone]-indoles: synthesis, COX-2 inhibition and anti-cancer activities.
Singh P; Mittal A; Bhardwaj A; Kaur S; Kumar S
Bioorg Med Chem Lett; 2008 Jan; 18(1):85-9. PubMed ID: 18061444
[TBL] [Abstract][Full Text] [Related]
3. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity.
Holla BS; Rao BS; Sarojini BK; Akberali PM
Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of pyrrolo[2,1-c][1,4]benzodiazepine and indole conjugates as anticancer agents.
Wang JJ; Shen YK; Hu WP; Hsieh MC; Lin FL; Hsu MK; Hsu MH
J Med Chem; 2006 Feb; 49(4):1442-9. PubMed ID: 16480280
[TBL] [Abstract][Full Text] [Related]
5. Anti-cancer activities of 5-acyl-6-[2-hydroxy/benzyloxy-3-(amino)-propylamino]-1,3-dialkyl-1H-pyrimidin-2,4-diones.
Singh P; Paul K
Bioorg Med Chem; 2006 Dec; 14(24):8622-5. PubMed ID: 16949293
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling.
Chao WR; Yean D; Amin K; Green C; Jong L
J Med Chem; 2007 Jul; 50(15):3412-5. PubMed ID: 17602463
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Kunkel MW
J Med Chem; 2006 Nov; 49(23):6922-4. PubMed ID: 17154522
[TBL] [Abstract][Full Text] [Related]
9. Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiation.
Natarajan A; Guo Y; Harbinski F; Fan YH; Chen H; Luus L; Diercks J; Aktas H; Chorev M; Halperin JA
J Med Chem; 2004 Oct; 47(21):4979-82. PubMed ID: 15456240
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiproliferative activity of [1,2,3,5]tetrazino[5,4-a]indoles, a new class of azolo-tetrazinones.
Barraja P; Diana P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2005 Jan; 13(2):295-300. PubMed ID: 15598552
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-one derivatives.
El-Nassan HB
Eur J Med Chem; 2011 Jun; 46(6):2031-6. PubMed ID: 21429629
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial, antitumor and 5α-reductase inhibitor activities of some hydrazonoyl substituted pyrimidinones.
Edrees MM; Farghaly TA; El-Hag FA; Abdalla MM
Eur J Med Chem; 2010 Dec; 45(12):5702-7. PubMed ID: 20933305
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and COMPARE analysis of bis-indole derivatives.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Landi L; Prata C; Dalla Sega FV; Caliceti C; Shoemaker RH
Bioorg Med Chem; 2010 May; 18(9):3004-11. PubMed ID: 20395150
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
[TBL] [Abstract][Full Text] [Related]
17. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition.
Panathur N; Dalimba U; Koushik PV; Alvala M; Yogeeswari P; Sriram D; Kumar V
Eur J Med Chem; 2013 Nov; 69():125-38. PubMed ID: 24013412
[TBL] [Abstract][Full Text] [Related]
19. New pyrimidinone and fused pyrimidinone derivatives as potential anticancer chemotherapeutics.
Rashad AE; Shamroukh AH; Yousif NM; Salama MA; Ali HS; Ali MM; Mahmoud AE; El-Shahat M
Arch Pharm (Weinheim); 2012 Sep; 345(9):729-38. PubMed ID: 22674829
[TBL] [Abstract][Full Text] [Related]
20. Simplified analogues of immucillin-G retain potent human purine nucleoside phosphorylase inhibitory activity.
Semeraro T; Lossani A; Botta M; Ghiron C; Alvarez R; Manetti F; Mugnaini C; Valensin S; Focher F; Corelli F
J Med Chem; 2006 Oct; 49(20):6037-45. PubMed ID: 17004717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]